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To study the mechanism of hormonal regulation of the 25-hydroxyvitamin D 24-hydroxylase, a DNA probe complementary to the published 
sequence of the recently cloned P450 component [(1991) FEBS Lett. 278. 195] was employed. Young (2 month) and adult (12 month) F344 rats, 
deficient in 1,25-dihydroxyvitamin D, were given a single dose of 1,25-dihydroxyvitamin D. In young rats. 1,25-dihydroxyvitamin D markedly 
increased P450 mRNA levels within 3 h in both kidney and intestine, and maximal levels were attained at 16 and 3 h, respectively. In adult animals, 
maximal induction of mRNA was diminished in the kidney, and the decline was slower in the intestine. Time of maximal induction did not change 
with age. These studies demonstrate for the first time regulation of the 24-hydroxylase enzyme by 1.25-dihydroxyvitamin D at the level of the mRNA 
for the cytochrome P450. They also demonstrate hat this regulation may change with age. 
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I. INTRODUCTION 
The kidney hydroxylates 25-hydroxyvitamin D in the 
l-position to form 1,25-dihydroxyvitamin D 
(1,125(OH),D), the most biologically active form of vi- 
tamin D, or in the 24-position to form 24,25-dihydroxy- 
vitamin D, whose biological function is unknown [1]. 
Both of these hydroxylations are accomplished by 
mixed function oxidases of the cytochrome P450 family, 
which are part of a multi-protein complex found on the 
inner mitochondrial membrane [2]. Although the l-hy- 
droxylation of 25(OH)D takes place almost exclusively 
in the kidney, 24-hydroxylase activity is found in inte- 
stine, bone, skin fibroblasts and lymphocytes, in addi- 
tion to kidney. The presence of 24-hydroxylase in these 
tissues, which are target tissues for 1.25(OH)2D action, 
has led to the suggestion that the 24-hydroxylation 
plays a role in the metabolic inactivation of 1,25(OHhD 
[3]. 
In the kidney, both the 1-hydroxylase (1-OHase) and 
the 24-hydroxylase (24-OHase) enzymatic activities are 
highly regulated by parathyroid hormone (PTH), 
1.25(OH)2D itscIK and other factors [2]. The hydroxy- 
lase activities tend to be regulated in a reciprocal fash- 
ion. PTH stimulates l-OHase activity and inhibits 24- 
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OHase activity [4], and 1,25(OH)2D inhibits I-OHase 
activity and stimulates 24-OHase activity [5]. The 
precise pathways by which PTH and 1,25(OH),D regu- 
late these hydroxylase activities are not known, but se- 
veral mechanisms have been proposed. These mecha- 
nisms include the regulation of transcription and trans- 
lation of components of the cytochrome P450 complex 
[6,7], the post-translational c eavage of synthesized 
components [8], and the post-translational phosl',horyl- 
ation of components [9]. 
With the recent isolation [10,11] and cloning [12] of 
the rat renal cytochrome P450 component of the 24- 
OHase, it is now possible to study the hormonal regula- 
tion of these hydroxylases in more detail. The experi- 
ments reported here were designed to determine 
whether the induction of the 24-OHase enzyme by 
1,25(OH)2D may involve an increase in mRNA levels 
for the P450 component. This was examined in both 
kidney and intestine using strontium-fed rats as a model 
for vitamin D deficiency [13]. In addition, the action of 
i,25(OH)2D was studied in adult as well as young rats, 
since the action of 1,25(OH),D in its target tissues has 
been reported to decline with age [14]. 
2. MATERIALS AND METHODS 
Experiments were performed using male virgin Fischer 344 rats 
(F344/NNIA), aged 2 (young) and 12 months (adult) ofage, Animals 
were obtained from the National Institute on Aging colony maintai- 
ned by Harlan Industries (Indianapolis, IN), Rats were initially led a 
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semisynthetic diet containing 1.2% calcium, 0.8% phosphorus, and 3.3 
IU/g vitamin D3 (Purina rodent chow, Ralston-Purina, St. Louis, 
MO). Animal studies were conducted in accord with the NIH Guide- 
lines for the Care and Use of Laboratory Animals. 
To make the rats deficient in 1.25(OH)zD. they were fed a low 
calcium diet (Teklad Test Diet no. 170120)containing 0.8% strontium 
for 6 days [14], This high strontium diet has been shown to markedly 
reduce serum 1,25-dihydroxyvitamin D, intestinal calcium transport, 
and intestinal calbindin content [14]. To determine the effect of 
1.25(OH),D on 24-OHase P450 mRNA. rats were given a single intra- 
peritoneal injection of 1,25(OH),D (300 ng/100 g body weight) dissol- 
ved in ethanol. Control rats (0 hour) were given vehicle only. Rats 
were killed at the indicated times after dosing with 1,25(OH).,D, and 
the abdominal cavity was exposed by midline incision. The proximal 
duodenum (0-10 cm distal to the pylorus) was removed, slit length- 
wise, and scraped with glass microscope slides to remove mueos~. 
Kidneys were also removed. Kidneys and intestinal mucosa were 
quick-frozen for later isolation of mRNA. 
The amount of 24-OHase P450 mRNA in the intestine and kidney 
was determined by Northern and dot blot as described previously [15]. 
Total RNA was isolated using guanidium isothiocyanate [16]. The 
RNA was probed using a synthetic eDNA probe based on the first 42 
bases of the published sequence for rat renal 24-OHase P450 [I 2]. The 
probe was 3' end labeled with deoxyadenosine monophosphate tails 
containing radiolabeled phosphorus II 7]. Northern blotting was used 
to assess the integrity of the isolated RNA and the validity of the 
probe. Dot blots were used to quantitate the amount of 24-OHase 
P450 mRNA [I 5]. After hybridization, the blots were autoradiograp- 
hed. and the X-ray films were quantitatcd by densitomctric s anning. 
Dot blots were quantitated in the linear range of RNA application. 
mRNA content was expressed per/~g of total RNA, which was deter- 
mined by optical density (OD). In addition, blots were stripped and 
rehybridized with a probe to p-actin (OnCor. Gaithersburg. MD), 
which was nick translated. /~-Actin. which is not affected by 1,25- 
dihydroxyvitamin D treatment [15], was used to verify the amount of, 
RNA on the dot blots. 
The data from these experiments arereported as the mean_+SE of 
the number of animals indicated. Statistical analyses were performed 
using two-tailed Student's t-test [18]. A confidence level of 95% or 
greater was considered significant. 
3. RESULTS 
To determine tissue specificity, Northern analysis was 
performed on total RNA isolated from kidney, inte- 
stine, and liver of rats dosed with 1,25-dihydroxyvita- 
min D 6 h previously. The oligonucleotide probe for the 
24-OHase P450 was found to hybridize strongly with 
RNA from the rat kidney and intestine but not with 
RNA from the liver (Fig. 1). A major band was seen at 
3.4 kb in the kidney, as has been reported previously 
using the full-length clone [12]. An identical band was 
found in the intestine, suggesting that the same mRNA 
may encode the 24-OHase P450 present in both tissues. 
Similar results were found using poly A RNA from 
these tissues (not shown). 
A single injection of 1,25(OH)2D produced a marked 
increase with time in 24-OHase P450 mRNA in the 
kidney (Fig. 2). In young rats, the renal mRNA levels 
were significantly elevated by 3 h, peaked at 16 11, and 
declined by 24-48 h. The adult rats showed a similar 
time course in response to 1,25(OH):D. However, the 
amount of P450 mRNA was less than that seen in the 
Fig. 1. Expression of mRNA for 24-hydroxylase P450 in kidney (A). 
intestine (B), and liver (C). Total RNA from each tissue was isolated 
from young rats treated with 1.25-dihydroxyvitamin D for 6 h. Nort- 
hern blotting of RNA was performed by electrophoresing i  agarose 
gel (21,26 and 23 ,ug in lanes A, B and C, respectively), blotting onto 
nitrocellulose, and incubating with the radiolabeled synthetic probe 
for the renal 24-OHase P450. The blot was autoradiographed, and 
message size was determined by co-clectrophoresis of size markers. 
Arrow indicates major band with a calculated size of 3.4 kb. 
young at each time point. This was particularly evident 
at 3-6 h, suggesting a lag in the action of 1,25(OH),D 
in the adult relative to the young. 
In the intestine, 1,25(OH),D also produced a rise in 
message lbr the 24-OHase P450 enzyme (Fig. 3). In the 
young animals, the maximal increase was seen at 3 h 
with a sharp decline thereafter. No message was detec- 
table in the intestine at 16 h, which was the time of 
maximal message concentration in the kidney. The 
adult animals showed a equally rapid rise in intestinal 
message, but the decline was much more gradual. The 
maximal evels of P450 message seen in the intestine did 
not change with age and were similar in magnitude to 
those seen in the kidney (Fig. 2). 
4. DISCUSSION 
These studies demonstrate he presence of 24-OHase 
cytochrome P450 mRNA in both the kidney and inte- 
stine and its stimulation by 1,25(OH),D administration 
in vivo. The fact that the P450 mRNA is found in the 
kidney and intestine but not in the liver correlates with 
the reported tissue distribution of 24-OHase activity 
[19]. Induction of the mRNA for the 24-OHase P450 by 
1,25(OH),D has not been reported in the intestine and 
kidney. An increase in renal 24-OHase P450 mRNA in 
response to chronic vitamin D administration has been 
previously reported [12]. However, in view of the poor 
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Fig. 2. Effect of 1,25-dihydroxyvitamin D and age on expression of 
24-hydroxylase P450 mRNA in kidney. Total RNA was isolated from 
kidney at indicated times after dosing with 1.25-dihydroxyvitamin D. 
mRNA for the 24-hydroxylase P450 was determined by dot blot using 
the radiolabeled synthetic probe for the renal 24-hydroxylase P450. 
Dot blots were quantitated by measuring the optical density of the 
autoradiographed dots. Each data point represents the mean±SE of 
6 rats and is expressed as optical density (o.d.) per mg total RNA. 
affinity of the vitamin D receptor f6r vitamin D compa- 
red to 1,25D [1], this increase was probably mediated 
by 1,25(OH):D itself. 
In general, the induction of 24-OHase mRNA by 
1,25(OH),D appears to be rapid enough and of suffi- 
cient magnitude to account for the increases in 24- 
OHase enzyme activity reported in previous tudies. In 
the experiments reported here, 1.25(OH)_,D increased 
24-OHase mRNA to 60% of maximum by 6 h in the 
kidney (Fig. 2) and to maximal levels by 3 h in the 
intestine (Fig. 3) in young animals. This is consistent 
with the fact that renal and intestinal 24-OHase activity 
has been reported to be elevated 6-17 h after 
1.25(OH).,D administration i the intact animal [20]. A 
similar time course is seen in experiments with cultured 
cells. In JTC-12 cells, a monkey kidney cell line, 24- 
OHase activity peaks at 4-8 h after 1,25(OH),D expo- 
sure [21]. In Caco-2 cells, a human colon adenocarci- 
~' 400 
-~ 300 














2 4 6 8 16 
Timo (Hours) 
Fig. 3. Effect of 1,25-dihydroxyvitamin D and age on expression of 
24-hydroxylase P450 mRNA in intestine, Total RNA was isolated 
from intestine at indicated times, and the 24-hydroxyla~e P450 mRNA 
quantitated by dot blot. See Fig, 2 for experimental details. 
noma cell line. 24-OHase activity peaks at 6-17 h after 
1,25(OH),D administration [22]. 
These experiments also demonstrate age differences 
in the response to 1,25(OH)2D. In the adult kidney, the 
response to 1,25(OH)2D was decreased at all time points 
compared to the young kidney (Fig. 2). This was espe- 
cially apparent at 3 and 6 h, where 24-OHase mRNA 
P450 levels in the adult were less than 30% of the young. 
However, the decline in mRNA levels from the peak at 
16 h was similar in both age groups. In the intestine, 
other differences were seen. In both the young and adult 
animals, there was a rapid increase in mRNA levels at 
3 h which was almost identical (Fig. 2). However, the 
decline in mRNA levels was much slower in the adult 
compared to the young. These findings suggest hat 
there may be age-related changes in the initiation of 
gene transcription in the kidney and in the stabilization 
of mRNA in the intestine in response to 1,25(OH):D. 
These age-differences were not due to changes in the 
metabolism of the injected 1,25(OH),D, since serum 
1,25(OH)2D levels in young and adu, lt rats were 
virtually identical at all time points (data not shown). 
In summary, these studies demonstrate for the first 
time that 1,25-dihydroxyvitamin D, which stimulates 
24-OHase activity, also increases the mRNA levels for 
the cytochrome P450 component of the enzyme com- 
plex. This is consistent with previous tudies which dem- 
onstrated that s imulation of activity by 1,25(OH):D 
was sensitive to transcription inhibitors [7]. The hor- 
monal regulation of other mitochondrial steroidogenic 
systems also involves increases in the mRNA for the 
appropriate P450. Adrenocorticotropin markedly in- 
creases the mRNA for the side chain cleavage cy- 
tochrome P450 in the adrenal cortex [23], and chorionic 
gonadotropin has a similar effect in the ovary [24]. The 
relative contribution of regulation at the mRNA level 
to the overall regulation of 24-hydroxylase activity 
remains to be determined. 
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